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Background: The need for detailed description and modeling of cells drives the continuous generation of large
and diverse datasets. Unfortunately, there exists no systematic and comprehensive way to organize these datasets
and their information. CELDA (Cell: Expression, Localization, Development, Anatomy) is a novel ontology for the
association of primary experimental data and derived knowledge to various types of cells of organisms.
Results: CELDA is a structure that can help to categorize cell types based on species, anatomical localization,
subcellular structures, developmental stages and origin. It targets cells in vitro as well as in vivo. Instead of
developing a novel ontology from scratch, we carefully designed CELDA in such a way that existing ontologies
were integrated as much as possible, and only minimal extensions were performed to cover those classes and
areas not present in any existing model. Currently, ten existing ontologies and models are linked to CELDA through
the top-level ontology BioTop. Together with 15.439 newly created classes, CELDA contains more than 196.000
classes and 233.670 relationship axioms. CELDA is primarily used as a representational framework for modeling,
analyzing and comparing cells within and across species in CellFinder, a web based data repository on cells
(http://cellfinder.org).
Conclusions: CELDA can semantically link diverse types of information about cell types. It has been integrated
within the research platform CellFinder, where it exemplarily relates cell types from liver and kidney during
development on the one hand and anatomical locations in humans on the other, integrating information on all
spatial and temporal stages. CELDA is available from the CellFinder website: http://cellfinder.org/about/ontology.Background
Cells are the building blocks of tissues and organs. The
central importance of cells in the establishment and
maintenance, as well as de- and regeneration of tissues,
has long been recognized [1-3]. Intense research has led
to the accumulation of an enormous and rapidly grow-
ing body of cell-related data in literature and different
databases. These diverse datasets capture different di-
mensions of cells, including subcellular structures, tran-
scriptome, temporal aspects such as the developmental
stage or potency and spatial aspects like anatomical* Correspondence: andreas.kurtz@charite.de
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reproduction in any medium, provided the orlocalization in vivo or cultivation conditions in vitro
(Figure 1).
In order to compare, characterize and determine the
type of cells based on cell-associated data, a systematic
representation of cells is necessary. In particular, the
context in which cell-associated data has been obtained
must be properly represented, as differences may lead to
grossly divergent characteristics and cell types. One
prominent example for this fact is that stem cell differ-
entiation in vitro frequently results in cells which have
no known equivalence in vivo [4].
Several attempts have been made to present available
information on cells in a unified format. For example
the CELLPEDIA database [5] provides a richly anno-
tated, intuitive resource for differentiated human cells by
including numerous data types and relating these to tis-
sues and organs in a way that makes it possible to dir-
ectly compare different cell types.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 An overview about the different classes that are used
to describe a cell type.
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of cell lines and cell types such as the human embryonic
stem cell database (hESCreg, [6]), the Characterization
Tool [4] or StemDB [7] and cell line banks like the
American Type Culture Collection (ATCC, [8]) or the
European Collection of Cell Cultures (ECACC, [9]).
Furthermore, to comprehend the domain of cell types,
several ontologies have been developed like the Cell
Ontology (CL, [10]) and the Cell Line Ontology (CLO,
[11]). Other ontologies describe the anatomy of or-
ganisms, which also include cells like the Foundational
Model of Anatomy (FMA, [12]), the Human Develop-
mental Anatomy (EHDAA, [13]) and the Mouse Adult
Gross Anatomy (MA, [14]).
In summary, several data sources provide means to
describe some of the many dimensions of information
on cells, but none provides a truly comprehensive frame-
work to address all or most of the available informa-
tion (see Table 1). In particular, an extensive overview
about cells of different species or developmental time
points cannot currently be easily generated in these
other databases.Table 1 Resources of CELDA: This table lists elements
that different sources of CELDA use to describe cell types
(x = covered; o = partially covered)
Cells in vivo Cells in vitro
CL Cellpedia CLO hESCreg Characterization
tool
Biological function x o
Histology x x x
Karyotype x
Lineage x x x x x
Marker x x x
Nuclear Number x
Origin x x x x x
Ploidy x x xTherefore, we developed a novel, comprehensive ontolo-
gy, CELDA (Cell: Expression, Localization, Development,
Anatomy) to formally represent important characteristics
of cell types. CELDA is intended to structure the growing
and diverse body of cell-related data. It allows for the de-
scription of cell types based on species, gender, anatomical
location, subcellular structures, developmental origin and
molecular composition such as gene expression. CELDA
also enables the comparative description of the develop-
ment of organs and tissues on the cellular level. Thereby,
CELDA can be used to generate developmental trees of
cell types, to compare cells in vivo with cells in vitro, or to
find similar cell types in different organs, tissues or spe-
cies. The ontology is designed to organize the vast and
heterogeneous body of cell-related data by linking com-
mon elements through precise annotation and is adap-
table to incorporate new information.
To establish CELDA, we addressed three fundamental
issues: (1) Which data and data sources on cell type de-
scription are available? (2) Which properties are needed
to fully describe cells in vivo and in vitro? and (3) How
does an ontology need to be designed in order to allow a
structured and standardized description of the properties
defined in (2)?
Methods
Ontology development
Ontologies are formal explicit descriptions of general
features of a certain domain. These general features are
described within an ontology by stating necessary (or ne-
cessary and sufficient) membership conditions for classes
(sometimes also called types). These classes are con-
nected with each other by means of formal relations
(which are also called object properties) [15].
In order to design an ontology development strategy,
we consulted the guidelines by Noy and McGuinness
[15], Bermejo [16] and Schulz et al. [17]. The first two
are by now somewhat dated and also contended, but
they were still useful to defined a four-step approach to
develop CELDA:
1. Determination of the classes within the domain and
scope of the ontology.
2. Evaluation of existing ontologies for their suitability
of utilization.
3. Development of the fundamental outline of the
ontology.
4. Formal representation of the ontology.
This four-step approach allows to create the ontology
in a structured way. This general framework was com-
bined with the modeling approaches suggested in the
“Good Practice Ontology Design Principles” by Schulz
et al., in particular for step 3 and 4.
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biology domain, we first analyzed existing ontologies
and databases. In addition, the opinion of domain ex-
perts and scientists in the field of biology, medicine and
cell biology were compared to identify criteria used to
describe cell types. The distinction between cell types
in vivo and in vitro happens to be crucial, as there is cur-
rently no data source that describes both variants of cell
types comparatively and in detail.
We selected the Cell Ontology as the main source for
cell types in vivo and the Cell Line Ontology, hESCreg,
and the Characterization Tool as sources for cell types
in vitro. Table 1 shows the properties used by these data
sources to describe cell types, which formed the basis
for selection of CELDA as shown in Figure 1. For de-
scribing both cell types in vivo and in vitro, we needed
to cover biological functions (e.g. the barrier function),
cytology and histology (including subcellular structures),
lineage (using the relation develops-from), expressed
genes, origin (e.g. anatomical location, species, gender,
age) and the genome status (e.g. ploidy) of the cell types.
In order to decide which ontologies to integrate within
CELDA, we performed an analysis of existing ontologies
dealing with different aspects of describing cells. The
Open Biomedical Ontologies Foundry (OBO) [18] pro-
vides a suite of orthogonal interoperable reference on-
tologies in the biomedical domain, including ontologies
for cells, anatomy, molecular functions, cellular compo-
nents, genes, proteins, phenotypes and development. Al-
though none of these ontologies by themselves fulfill
CELDA’s requirements, they provide a reasonable cover-
age of the domain if taken together.
Therefore, we decided to utilize as many classes as
possible from these existing ontologies and to apply a
top-level ontology which provides an ontological layer
for linking and integrating various specific domain on-
tologies [19].
There are several upper-domain ontologies that have a
focus on life sciences. We evaluated
– Ontology of Biomedical Reality (OBR) [20]
– Simple Bio Upper Ontology [21]
– General Formal Ontology (GFO-BIO) [22]
– BioTop [23].
We decided to use BioTop because it is founded upon
formal design principles (as advocated by the OBO
Foundry initiative), implemented in OWL2 and has a
biological focus. Another advantage of BioTop is that it
was actually designed to connect with important OBO
Foundry ontologies and contains built-in bridge classes
that serve this purpose [23].
BioTop can be used without an additional top-level
ontology, but there are also bridges that allow itscombination with either the Descriptive Ontology for
Linguistic and Cognitive Engineering (DOLCE) [24] or
the Basic Formal Ontology (BFO) [25]. BioTop itself is
not part of the OBO Foundry [18], but the bridge allows
it to import BFO, which is the top-level ontology that is
part of and recommended by the OBO Foundry. We
used relations as defined in BioTop and the OBO Rela-
tion Ontology (RO) [26].
In order to cover all the sub-domains needed for a full
representation of all relevant aspects of cell types, we re-
used existing ontologies and extended them when neces-
sary. A list of the sub-domains can be seen in Figure 1.
Likely the most prominent ontology that describes cell
types is CL, which describes in vivo cell types. It con-
tains formal definitions for cell types, referring for ex-
ample to the phenotypic characteristics of cell types
[27]. CLO describes cell lines and their origins [11]. The
Experimental Factor Ontology (EFO) [28] also contains
a considerable number of classes for cell lines and cell
types, linking cell line classes to both anatomical entities
and diseases.
Biological processes are covered by both the Gene
Ontology (GO) in its sub-ontology ‘Biological process’, as
well as in EFO. The substructures of cells can be de-
scribed by referring to the classes for subcellular struc-
tures in the GO [29]. Furthermore, some extensions and
mapping ontologies are available from the OBO Foundry
to extend the GO on behalf of cellular components and
biological processes [30]. We also made use of these in
order to develop a description of our domain as com-
pletely as possible.
The lineage of cell types is described in CL, CLO and
EFO. These ontologies also partially address the origin
of cell types, but only EFO contains terms to describe
the species of origin. While both CLO and EFO contain
terms to distinguish between sexes, only EFO contains
terms for age. To fully describe the origin of cell types,
ontologies from the anatomical domain can be used.
The UBERON ontology [31] describes anatomical terms
without reference to species, while other ontologies are
specific to one species, like the Foundational Model of
Anatomy (FMA) [12] and Human Developmental Anat-
omy (EHDAA) [13] for human or the Mouse Adult
Gross Anatomy (MA) [14] for mouse. A mapping ontol-
ogy from UBERON to species-specific ontologies like
FMA or MA is also available at the OBO Foundry [32].
The genome status of cell types is partially described in
the CL. A complete overview of the examined ontol-
ogies, their coverage of cell biological classes and further
data sources are shown in Table 2.
For the construction of the ontology, we organized
both the ontologies imported for re-use and the classes
newly defined by us in a hierarchical structure using the
top-level ontology BioTop together with the BioTop
Table 2 Classes for the representation of cell types and available ontologies and data sources which cover these
domains
Class Information types Ontologies Other datasources
Cell types • Names and description of cell types • CL [10]
Cell lines • Names and description of cell lines • CLO [11] • hESCReg [6]
• EFO [28] • Characterization Tool [4]
Biological function • Biological function • EFO
• Molecular processs • GO [29]
Histology • Components and substructures • CL • hESCreg
• Morphology • GO
• GO_XP_ALL [30]
• Cellular_component_xp_self [30]
• Cellular_component_xp_go [30]
• Cellular_component_xp_cell [30]
Lineage • In vitro: origin cell • CL • hESCreg
• In vivo: developmental tree • CLO
• EFO
Marker/Gene Expression • Expressed genes • Biological_process_xp_cell [30] • Characterization Tool
• Biological _process_xp_uber_anatomy [30] • hESCreg
• Biological_process_xp_multi_organism_process [30]
• Biological_process_xp_self [30]
• Biological_process_xp_cellular_component [30]
Origin • In vivo: anatomical location in
tissue/organ
• CLO • hESCreg
• In vitro: environmental clue • CL
• Species • FMA [12]
• Gender • MA [14]
• Age • UBERON [31]
• Developmental stage • EHDAA [13]
• uberon_anatomy_ontologies_bridge [32]
The ontologies and bridges for mapping can be found at the OBO Foundry, http://www.obofoundry.org. hESCreg and the Characterization Tool are available at
http://www.hescreg.eu and http://characterizationtool.cellnet.org.
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of CELDA. Since we intended to use CELDA as a basis
for the CellFinder application (http://cellfinder.org), local
copies of the ontologies were generated and imported
into CELDA. This allows functionality of CELDA inde-
pendently of external changes to some of the ontologies.
When changes in one of the imported ontologies occur,
CELDA can be tested with the new version of the ontol-
ogy and after confirmation of stability, our local copy
can be updated.
According to Courtot et al. [33], there are three
general possibilities when referencing external ontology
sources:
1. create own classes and reference other ontology
classes,2. generate and import modules of other ontologies,
3. import whole resources.
In most cases, we decided to import the whole resource.
One major principle of the OBO Foundry is that every
ontology should, in principle, cover a particular domain
that is not covered by other ontologies. Hence, the ontol-
ogies we used from the OBO Foundry are intended to be
orthogonal to each other and, thus, this approach did not
lead to massive overlap. When no classes existed in the
imported ontology for a cell type, cell line or anatomical
entity we wanted to describe, we built the necessary clas-
ses ourselves and included them directly in CELDA. These
classes were linked to classes from existing ontologies.
In a final step, we implemented the ontology in the
Web Ontology Language (OWL, [34]). For this purpose,
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linking of classes from different ontologies, we used the
Jena API [36], a Java framework for building semantic
web applications. The Jena API was also used to add in-
formation from hESCreg and Characterization Tool da-
tabases to existing ontology classes and to develop new
classes when necessary.
Evaluation
Several approaches exist to evaluate new ontologies.
Obrst et al. suggested six different evaluation techniques
for the use of ontologies in life sciences [37-39]:
1. assessment by humans against a set of criteria
2. comparison of the ontology against a set of criteria
3. evaluate the use of the ontology in an application
4. natural language evaluation techniques
5. ontology accreditation and certification
6. use reality as a benchmark.
We created CELDA especially for use in CellFinder;
therefore, our focus for evaluation was the performance
of CELDA within this application (technique 3). InFigure 2 Linking of ontologies in CELDA using BioTop. This diagram sh
and UBERON are linked together in CELDA using BioTop. Read from top toaddition, we compared CELDA with existing ontologies
and data sources during the whole developmental process
(technique 2). The ontology was also checked by domain
experts (technique 1).
Results
Developing the fundamental outline
When analyzing the available ontologies describing one
or more of the domains needed to describe cell types
(see Figure 1), we found eight ontologies covering at
least one of these domains: CL, CLO, EFO, EHDAA,
FMA, GO, MA and UBERON. These were then linked
using the top-level ontology BioTop as shown in Figure 2.
CLO and EFO already provide a connection to BFO.
Therefore, we also used a bridge between BioTop and
the BFO and RO [40].
CL was linked to BioTop by defining CL:Cell as
equivalent to BioTop:Cell. UBERON was linked to
BioTop with a rdfs:subclassOf relation between BioTop:
organism part and UBERON:anatomical entity and with
a rdfs:subclassOf relation between UBERON:processual
entity and BioTop:Process. To link the EHDAA, the
FMA and the MA with BioTop, we created two newows how high-level classes of CL, CLO, EFO, EHDAA, FMA, GO, MA
bottom, the lines represent rdfs:subclassOf relations.
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mouse anatomical entity. These two classes were linked
to UBERON:anatomical entity with a rdfs:subclassOf
relation. We then linked FMA:anatomical entity and
EHDAA:anatomical entity with CELDA:human anato-
mical entity and all top-level classes from the MA with
CELDA:mouse anatomical entity using the rdfs:sub-
classOf relation. The three GO root classes were also
linked to BioTop by the rdfs:subclassOf relation. We
linked GO:biological process with BioTop:bio molecular
process and GO:molecular function with BioTop:molecu-
lar function. Finally, we declared GO:Cellular Compo-
nent to be equivalent to BioTop:Cellular Component.
After creating this scaffold for CELDA, we used the
reasoner HermiT version 1.3.6. [41] to test the logical
consistency after the linkage of the diverse ontologies.
During the classification, no inconsistencies were repor-
ted by HermiT.
We then imported the entirety of resources from CL,
CLO, EFO, EHDAA, FMA, GO, MA and UBERON into
this scaffold. To make sure that the classes of the diverse
ontologies were properly mapped to each other, we used
ten mappings and bridges provided by the OBO Foundry
(Table 1):
 cellular_component_xp_self.
 cellular_component_xp_go.
 cellular_component_xp_cell.
 Biological_process _xp_cell.
 biological _process_xp_uber_anatomy.
 Biological_process_xp_multi_organism_process.
 biological_process_xp_self.
 biological_process_xp_cellular_component.
 uberon_anatomy_ontologies_bridge [32].
 molecular_function_xp_uber_anatomy [42].
For some of the imported ontologies, no bridges were
available. For these ontologies, we created mappings
ourselves using the JENA API. New bridges were created
between:
 CL and MA.
 CL and FMA.
 EHDAA and FMA.
 CL and UBERON.
Altogether, more than 196.000 classes for cell types,
cell lines and anatomical entities were included from
eight different ontologies in the CELDA ontology. In
CELDA, 15.439 classes were newly defined together with
203.058 relations involving these classes. The OWL file
CELDA_import.owl contains the top-level structure as
well as the newly-defined classes together with the
axioms stating the relations of these classes to classesfrom other ontologies. The file CELDA.owl imports
CELDA_import.owl together with all ontologies and
bridges as described above.
Representation of cell types
The structure shown in Figure 3 gives an overview of how
we represent the domains needed to describe cells (see
Figure 1) in CELDA with some of the high-level classes.
Among the generic names for cells, we distinguish
names for cell types and cell lines. Cell type names are
general terms that describe cells with similar or identical
properties (e.g. “embryonic stem cell”, “induced pluripo-
tent stem cell”), while names for cell lines refer to
groups of similar cells of an in vitro type (e.g. “hESC line
H1”, “lung fibroblast line IMR90”). Cell lines, on the
other hand, are permanently established cell populations
consisting of cells in vitro from exactly one cell type.
Such a population can be modeled as a collection with
in vitro cells as grains [43]. While cell types find their
way into CELDA as subclasses of the class Cell, the
grains of cell lines are instances of CL: experimentally
modified cell in vitro.
There are important relations between cells such as
the ability for one to develop from another cell. A cell
in vitro can be derived from a cell in vivo of a certain
type. Cells can be characterized by their location (within
an anatomical entity), their subcellular structures and
their expression patterns, i.e. by the biomolecules they
contain. Such characterizations may also allow finding
cell types with similar properties from different species.
A cell can be an organism by itself (prokaryotic cells) or
part of an organism. OWL would allow the inclusion of
individuals in order to represent particular cells, though
this would transcend the purpose of an ontology proper.
Most of the imported ontologies contain a class called
“cell” or “cell type”. Therefore, careful analysis and the
relation of these terms to each other was needed to de-
fine which terms are equivalent to each other and which
classes are to be treated as subclasses. The result is
shown in Figure 4. The EFO contains a class called “cell
type” with a matching definition (“distinct morphological
or functional form of cell”), but the subclasses (e.g. “blast
cell” or “fibroblast”) make it clear that the instances of
these classes are, in fact, cells and not cell types or cell
forms. For this reason, we interpreted EFO:cell type as a
class of cells whose subclasses categorize cells according
to their type or form.
Application of CELDA within the cell-related data
repository CellFinder
CELDA has been developed in order to be used within
the CellFinder project (http://cellfinder.org). CellFinder
is a web-based data repository for scientific statements
about cell types created and maintained at the Berlin-
Figure 3 Domain representation in CELDA. CELDA distinguishes between cells and cell lines. Subclasses of cells describe groups of cells
with similar properties like developmental stage, anatomical location, cellular structures or expressed molecules in vitro or in vivo. Cell lines are
permanently established cell populations consisting of cells in vitro from exactly one cell type.
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CellFinder is aiming at an integral representation of data
on cell types in the context of molecular, phenotypic,
anatomical and developmental information in health and
disease across species. CELDA is used as a backbone
within CellFinder to enable integration of diverse primary
datasets. An important application of CELDA is to link
and organize in vivo and in vitro derived data regarding
cell types (e.g. gene expression profiles, morphological and
anatomical information including images), the origin of
the cell types, references and the relations among these
datas. For example, CELDA was used to position human
parietal visceral epithelial cell in the developmental tree
of kidney cell types and to find cell lines with similar de-
scriptions (Figure 5). Furthermore, it is now possible to
associate images of cells displaying morphologies, anatom-
ical location or subcellular structures with gene expression
data. These can be further related to the spatial and tem-
poral context of the cell type. An example of the context
of a cell type is the glomerulus and the kidney for human
glomerular visceral epithelia. Any neighboring, similar or
related cell types in other species can then be directly
identified using a class from CELDA.
CELDA also allows comparing in vivo cell types with
cell lines in vitro. Figure 6 shows an example of a human
embryonic stem cell line H1in vitro that is derived from
the inner cell mass of a human embryo, which is part of
the human blastocyst in vivo.Evaluating CELDA in the kidney domain
The degree and accuracy of characterization and analysis
within CELDA depends largely on the cell-related data
that is integrated in the ontology. To test the application
of CELDA on the representation of developmental trees,
we chose to represent cell types involved in human kid-
ney development in order to reduce the data scope.
Using a set of domain related publications and online
tools [44-53], the developmental tree for human kidney
cells starting from the zygote was created by domain ex-
perts working in the field of kidney regeneration.
Altogether, we found 145 cell types taking part in kidney
development. 75 of these cell types in the developmental
tree were not part of the CL and were included in
CELDA based on manual data extraction from the
sources mentioned above. The developmental tree can
be viewed online at http://cellfinder.org/development.
As the cell types described in CL are species-
independent, we extended CELDA with species-specific
classes for each of the 145 identified cell types relevant
for kidney development when no equivalent class was
found in FMA or EHDAA for human or in MA for
mouse. These classes were linked to the species-
independent classes using a rdfs:SubclassOf relation.
These classes were then linked to UBERON for
species-independent cell types using the ro:part_of rela-
tion. Human-specific cell types were linked to classes in
FMA and EHDAA and mouse-specific cell types were
Figure 4 How to connect various classes with the label “cell”. Several of the ontologies imported into CELDA contain classes labeled “cell” or
“cell type”. The figure shows which of these are stated to be equivalent or connected by means of rdfs: subclassOf relations in CELDA.
Figure 5 An extract from the representation of a ‘parietal epithelial cell’ in the CELDA ontology. Extra classes for a detailed description of
these cell types were included, and the ro:develops from relations where added. Furthermore, we linked the cell types to the anatomical entities
where they occurred.
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Figure 6 An extract of the representation of the human embryonic cell line H1 and the relation to its in vivo counterpart in the CELDA
ontology. We added new cell lines like H1 as described in hESCreg when they are not already contained in the CLO.
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linked among each other using the ro:develops_from re-
lation to represent the developmental history of cells. A
section of the developmental tree generated with CELDA,
showing the development of a myoblast, can be seen in
Figure 7.
When a cell type is characterized by specific cellular
structures, this class is linked to classes from GO des-
cribing the cellular structure using the BioTop:has_
component_part relation .
Discussion
CELDA is an ontology for the formal description of cell
types built by using and carefully extending existing
ontologies from the biological domain. It integrates dif-
ferent dimensions of cell types at the genetic, molecular,
structural, functional, temporal and spatial level. It also
addresses the organization of cell types into higher-
order structures (e.g. develops from or anatomical
location).
CELDA aims to reflect the language used by re-
searchers in laboratories and publications to distinguish
between cell types. Accordingly, the design process of
CELDA could be described as being data-driven because
we focus on representing those kinds of data which are
regularly generated in laboratories and on making themintuitively useable for semantic inferencing over cell
types. A disadvantage of such a data-driven process in
contrast to a model-driven process is the need for
change when new technologies emerge. However, new
technologies can be integrated into CELDA and would
only require slight modifications. We believe that the
ways in which cell types are described will most likely be
straightforward extensions of our core model, especially
when novel molecular, substructural and physical data
become available.
When re-using existing ontologies, we store them on
our server and use this version instead of using other
versions provided, for example, by the OBO Foundry or
by the authors of the ontologies. This allows CELDA to
be independent of these data sources and assures that
the ontologies are available in the version needed. This
is important for the reliable functioning of any applica-
tion that, like CellFinder, uses CELDA as its data struc-
ture. The disadvantage of this approach is that the
ontologies are not always up-to-date; it is necessary to
search manually for updates, check their compatibility
and then integrate them.
CELDA was designed to allow researchers to find cell
types through their properties and to reason about vari-
ous kinds of relationships between different cell types.
The availability of data from diverse domains makes it
Figure 7 An extract of the developmental tree of cells that is
part of the CELDA - Ontology. Read from top to bottom, the lines
represent the ro: develops from relation.
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different domains and relate them with similar cells, e.g.
of different species, developmental stage or from the
in vitro or in vivo domains (See Figure 6). By serving as
a data model for the CellFinder data repository, CELDA
has provided a proof of concept that it may be suitable
for scientific applications in cell biology.
Up to now, CELDA primarily includes data on the de-
velopment of the human kidney on a cellular level. The
current work on CELDA focuses on describing the
development of liver and skin cell types and to cha-
racterize stem cells in vivo and in vitro in develop-
mental differentiation.
When creating CELDA, we faced several problems.
One major problem was the occurrence of similar or
identical classes in different ontologies. We tried to findthem automatically by searching for identical names and
using reasoning, but due to variant forms of spelling and
the use of synonyms, it was not always possible to auto-
matically find all occurrences. We are working on identi-
fying equivalences manually, but the completion of this
task will require some time due to the enormous and in-
creasing amount of data. It will be of great benefit if fur-
ther updates of the integrated ontologies deal with such
problems like using a standardized naming convention
or including references to equivalent classes in other
ontologies.
Another problem occurred when dealing with terms
that occur in the same or in similar forms in several of
the integrated ontologies, perhaps with different explicit
definitions. Major examples are, obviously, the terms
“cell” and “cell type”. The label “cell”, e.g., could be used
for the class of all cells, (in GO) for the class of cells
in vivo, or even (in FMA) for the class of human cells
in vivo. The label “cell type” probably rests on a confu-
sion between the two relations of instantiation and
subclasshood (which are not distinguished, e.g., in many
thesauri [54]). While subclasses of the class Cell are, of
course, types of cells, all instances of Cell are particular
cells that exist at a certain time and could, e.g., be
viewed under the microscope. A closer inspection of the
use of the label “cell type” showed that its instances (or
at least instances of subclasses) were, in fact, meant to
be particular cells. The general lesson to be learnt is that
ontology designers should be very careful with the nam-
ing and should also have an eye on problems that could
occur when the ontology to be developed is combined
with other resources. Naming conventions, like those
provided by the OBO Foundry community [55], can help
to prevent such problems.
A difficult issue was brought up by the question of
when to call a cell a human cell. In canonical cases,
human cells are (1) part of a living human organism
and (2) derive from a human zygote. A baboon heart
transplanted to a human organism may fulfill the first
criterion, but not the second, whereas human brain cells
transplanted to mice fulfill the second criterion, but after
the transplantation no longer the first. Cells of multicel-
lular organisms are called “in vivo cells” if they are part
of a living organism. The existence of xenografts, how-
ever, shows that we have to distinguish between several
cases: (1a) cells within the organism that developed from
the same zygote from which the cell developed, (1b) cells
within an organism that developed from a zygote of the
same species as the zygote from which the cell devel-
oped, and (2) cells within an organism of a different spe-
cies. The strictures of description logics (on which OWL
is based) do not allow us to distinguish between the
cases (1a) and (1b), but they allow us to set off (2) as a
distinct possibility.
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cell in vivo” for cells only that fulfill both criteria, i.e.
that developed from a human zygote and are part of
a living human organism. This implies that a human
cell which is transplanted to another organism does not
count as “human cell in vivo” anymore. This decision
was motivated by the biological point of view that we
use to describe cells. From the biological point of view,
xenografts are artificial systems and not in their natural
environment. As the canonical environment of cells
would be too complex to be described in detail, we need
to reserve the modifier “in vivo” as a shortcut for those
cells that interact with their canonical environment and
are likely to show typical properties, whereas cells out-
side of this canonical environment may behave quite dif-
ferently. In order to also cover the non-canonical cases,
we included a class Xenograft cell in CELDA, which can
be used to describe such transplanted cells.
Using an ontology to organize the information on cells
provides the possibility for automatic reasoning to gain
new hypotheses as described by Meehan et al. [27]. They
expanded the CL and used automatic reasoning to find
mistakes in the ontology. The reasoners exposed areas
in the ontology where new classes were needed to ac-
commodate species-specific expression of cellular mar-
kers and inferred new relationships within the CL and
between the CL and the contributing ontologies. Fur-
thermore, reasoners allow finding inconsistencies in the
ontology as we have shown in the result section. Unfor-
tunately, current reasoners have limitations when dea-
ling with large ontologies. For example, HermiT [41]
only supports the usage of 1 GB RAM. Thus, in the case
of CELDA, reasoning over the complete ontology is
problematic. Therefore, we decided to use reasoning
only as a tool to check parts of the ontology for incon-
sistencies as detailed above in the result section. How-
ever, it would be very desirable to reason with the
complete resource or at least with larger parts of
CELDA in order to gain new hypotheses on cell func-
tion based on similarity to other cell types. We hope that
future versions of reasoners, in combination with im-
proved hardware, will be able to process large ontologies.
Finally, it should also be noted that CELDA, like many
other ontologies, is not yet complete. Many developmen-
tal processes in organisms are, at present, only described
for tissues, but not on the cellular level. Therefore,
CELDA can grow when future research provides new in-
sights. Given the large number of classes to be repre-
sented and the growing and still versatile body of
knowledge in this domain, it is unrealistic to use manual
curation as the sole strategy. However, the development
of automatic mechanisms to limit or eliminate duplica-
tions and redundancies on the top level remains an on-
going task.Conclusions
The new ontology, CELDA, integrates and extends
already existing ontologies in order to represent cell
types as described in current research. CELDA relates
cell types not only to other cell types, but also to ana-
tomical components and cellular structures from other
OBO library ontologies. In the long term, we expect that
biological databases will move beyond a histology and
gene-centric view and biological mechanisms will be
studied at a more integrated level. Since cells are the
biological units from which tissues, organs and pheno-
types are built, this transition will be facilitated by rich
and explicit description of cell types across phyla that
can be adapted by biological databases. We believe that
CELDA will support standardization and comparability
of the complex datasets for each cell and organize these
in a cellome environment. The outline of CELDA pro-
vides for the first time a solution to facilitate the integra-
tion of ontologies from multiple domains that can also
be applied to other cell-centered data repositories.
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